NDC product
Tizanidine
NDC 35356-662 · Quality Care Products, LLC
Key facts
| Product NDC | 35356-662 |
|---|---|
| Proprietary name | Tizanidine |
| Nonproprietary name | Tizanidine |
| Substances | TIZANIDINE HYDROCHLORIDE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Quality Care Products, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA076286 |
| Pharmacologic classes | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
| Marketing start | Feb 6, 2007 |
| Marketing end | Mar 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory